Cargando…

Editorial: Risks and Benefits of Adjuvants to Cancer Therapies

Detalles Bibliográficos
Autores principales:	Dong, Peixin, Gewirtz, David A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149592/ https://www.ncbi.nlm.nih.gov/pubmed/35651808 http://dx.doi.org/10.3389/fonc.2022.913626

Ejemplares similares

The Survival Benefits of Surgical Resection and Adjuvant Therapy for Patients With Brainstem Glioma
por: Liu, Zhuoyi, et al.
Publicado: (2021)

Integrative Radiogenomics Approach for Risk Assessment of Postoperative and Adjuvant Chemotherapy Benefits for Gastric Cancer Patients
por: Jin, Yin, et al.
Publicado: (2021)

Editorial: Insights into non-coding RNAs in programmed cell death, from molecular mechanism of tumorigenesis to therapeutic targets
por: Liu, Jinhui, et al.
Publicado: (2023)

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
por: Chen, Xin, et al.
Publicado: (2022)

Editorial: Interplay between RNA-binding proteins and non-coding RNAs in tumor therapeutic resistance
por: Dong, Peixin, et al.
Publicado: (2023)

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma
por: Wang, Daijun, et al.
Publicado: (2020)

Case Report: Adjuvant Crizotinib Therapy Exerted Favorable Survival Benefit in a Resectable Stage IIIA NSCLC Patient With Novel LDLR–ROS1 Fusion
por: Chen, An-guo, et al.
Publicado: (2022)

Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
por: Khan, Shaheer, et al.
Publicado: (2022)

Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy
por: Saleh, Tareq, et al.
Publicado: (2018)

Particle Therapy for Breast Cancer: Benefits and Challenges
por: Luo, Wanrong, et al.
Publicado: (2021)

Editorial: Nanomedicine in Cancer Targeting and Therapy
por: Longo, João Paulo Figueiró, et al.
Publicado: (2021)

Calreticulin as Cancer Treatment Adjuvant: Combination with Photodynamic Therapy and Photodynamic Therapy-Generated Vaccines
por: Korbelik, Mladen, et al.
Publicado: (2015)

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
por: Zaorsky, Nicholas G., et al.
Publicado: (2020)

Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study
por: Chen, Zhiju, et al.
Publicado: (2020)

Editorial: Mechanisms and Therapy for Cancer Metastasis to the Central Nervous System
por: Zhao, Haotian, et al.
Publicado: (2019)

MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
por: Lahooti, Behnaz, et al.
Publicado: (2021)

Editorial: Molecular influences in therapies in ovarian cancer
por: Restaino, Stefano, et al.
Publicado: (2022)

Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer
por: Gallagher, Lindsey, et al.
Publicado: (2023)

Neo–adjuvant hormonal treatment for the undescendent testis – a benefit for the patient?
por: Stein, Raimund
Publicado: (2013)

Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2017)

Editorial: Investigations into the potential benefits of artificial intelligence and deep learning to surgical oncologists
por: Williams, Simon C., et al.
Publicado: (2023)

Adjuvant Therapy for Resectable Biliary Tract Cancer: A Bayesian Network Analysis
por: Chen, Xiuqiong, et al.
Publicado: (2021)

Editorial: Self-Eating on Demand: Autophagy in Cancer and Cancer Therapy
por: Lane, Jon D., et al.
Publicado: (2017)

Editorial: Advances in molecular targeted therapies of urologic cancers
por: Nitzsche, Bianca, et al.
Publicado: (2022)

Editorial: Cancer Metabolism: Molecular Targeting and Implications for Therapy
por: Ganapathy-Kanniappan, Shanmugasundaram
Publicado: (2017)

Editorial: LncRNAs in Cancer Metastasis and Therapy Resistance
por: Ahmad, Aamir, et al.
Publicado: (2021)

Editorial: Novel Combination Therapies for the Treatment of Solid Cancers
por: Ayoub, Nehad M.
Publicado: (2021)

Editorial: Local ablative therapies for the management of lung cancer
por: Wei, Zhigang, et al.
Publicado: (2023)

Editorial: Novel signaling pathways and therapy in breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2023)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis
por: Zheng, Si-Yue, et al.
Publicado: (2022)

Curcumin as an Adjuvant to Cancer Immunotherapy
por: Paul, Silpita, et al.
Publicado: (2021)

Plasma oncology: Adjuvant therapy for head and neck cancer using cold atmospheric plasma
por: Li, Xuran, et al.
Publicado: (2022)

Targeted Therapy; From Advanced Melanoma to the Adjuvant Setting
por: Ahn, Antonio, et al.
Publicado: (2013)

Current Status of Intensified Neo-Adjuvant Systemic Therapy in Locally Advanced Rectal Cancer
por: Engels, Benedikt, et al.
Publicado: (2012)

Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer
por: Pisapia, Pasquale, et al.
Publicado: (2022)

Editorial: Cancer stem cells as attractive targets for breast cancer therapy
por: Ibrahim, Sherif Abdelaziz, et al.
Publicado: (2023)

Editorial: Proton Therapy in Cancer Treatment: Clinical Evidence and Controversies
por: Timmermann, Beate
Publicado: (2022)

Editorial: Oncolytic Viruses—Genetically Engineering the Future of Cancer Therapy
por: Gesundheit, Benjamin, et al.
Publicado: (2017)

Editorial: Cancer Plasticity and the Microenvironment: Implications for Immunity and Therapy Response
por: Behren, Andreas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bvdg0fvo2n4v2dcfhm2rc5gisi